NYSE: NHINational Health Investors Inc Stock
$71.20+0.11 (+0.15%)
Updated Jul 11, 2025
NHI Price
$71.20
Fair Value Price
N/A
Market Cap
$3.32B
52 Week Low
$65.13
52 Week High
$86.13
P/E
22.39x
P/B
2.33x
P/S
9.85x
PEG
1.27x
Dividend Yield
3.79%
Revenue
$342.97M
Earnings
$141.20M
Gross Margin
87.5%
Operating Margin
58.48%
Profit Margin
41.1%
Debt to Equity
0.94
Operating Cash Flow
$213M
Beta
0.52
Next Earnings
Aug 11, 2025
Ex-Dividend
Jun 30, 2025
Next Dividend
Aug 1, 2025
NHI Overview
National Health Investors Incorporated specializes in sale-leaseback, joint venture, and mortgage and mezzanine financing of senior housing and medical facilities in 33 states. Its portfolio is made up of 212 real estate investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and a specialty hospitals. NHI was founded in 1991 and is headquartered in Murfreesboro, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NHI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
NHI
Ranked#6 of 16
Ranked#6 of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.23 | C | |
| $30.73 | C | |
| $3.72 | C |
Be the first to know about important NHI news, forecast changes, insider trades & much more!
NHI News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NHI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NHI ($71.20) is trading above its intrinsic value of $37.54, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NHI is good value based on its earnings relative to its share price (22.39x), compared to the US market average (30.99x)
P/E vs Market Valuation
NHI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NHI due diligence checks available for Premium users.
Valuation
NHI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.39x
Industry
80x
Market
30.99x
NHI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NHI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NHI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.33x
Industry
2.28x
NHI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NHI price to earnings growth (PEG)
For valuing profitable companies with growth potential
NHI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
NHI's financial health
Profit margin
Revenue
$89.3M
Net Income
$34.2M
Profit Margin
38.2%
NHI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.8B
Liabilities
$1.3B
Debt to equity
0.94
NHI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NHI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$46.5M
Investing
-$75.5M
Financing
$139.8M
NHI vs Healthcare Facility REIT Stocks
National Health Investors Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.